DHR Stock Analysis: Danaher Corp
Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development.
- Latest close
- $221.55
- 20-day change
- +3.74%
- Trend state
- NEUTRAL
- Classification
- Healthcare · Medical - Diagnostics & Research
Market context
Danaher Corp moved +3.74% over the latest 20-session window. BullRecon currently classifies the broader setup as NEUTRAL.
Latest report
The latest cached company filing period (FY2025 · $24.6B revenue · $3.6B net income) is used alongside annual and quarterly history. Values remain tied to their reported period.
Six-dimension read
Health is currently the strongest dimension at 5.0/6, while Growth is the lowest at 3.3/6. Scores are comparative research signals, not forecasts.